Subcutaneous adipose tissue measurements and better metabolic prediction
The aim of the study was to establish the importance of an additional measurement of subcutaneous adipose tissue thickness (SAT) on a predetermined position on the waistline, and its relation to waist measurements as an improvement of metabolic prediction in equally obese subjects. One hundred and forty two consecutive patients were enrolled in the study: stratified by weight as normal (body mass index — BMI 20–25 kg/m2), overweight (BMI 25–30 kg/m2) and obese (BMI >30 kg/m2); and by fasting glucose level as normoglycemic, impaired fasting glucose (IFG), or with type 2 diabetes mellitus (T2DM). SAT was measured in relaxed expiration, 3 cm left of the umbilicus, with ultrasound. Fasting blood samples for glucose, insulin and HbAlc were taken. Waist circumference was slightly higher in the IFG (112.8 cm) and normoglycemic groups (115.62 cm), compared to T2DM (108.15 cm). The T2DM group had a lower average SAT (2.7 cm) than both the IFG group (3.4 cm, p<0.01) and the normoglycemic group (4.2cm, p=0.001). The homeostatic model of assessment for insulin resistance (HOMA IR) was the lowest in normoglycemic and the highest in IFG group. Waistline radius to SAT ratio provides better insight into the deterioration of glucose metabolism than standard anthropometric markers of abdominal obesity in equally obese patients.
KeywordsSubcutaneous adipose tissue thickness Glucose metabolism deterioration Central adiposity
Unable to display preview. Download preview PDF.
- Garaulet M., Pérez-Llamas F., Pérez-Ayala M., Martínez P., de Medina F.S., Tebar F.J., et al. Site specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterran area:relation with dietary fatty acids, plasma lipid profile, serum insulin and central obesity Am J Clin Nut 2011; 74: 585–591Google Scholar
- Grill V., Björklund A. Type2 diabetes-effect of compensatory over secretion as a reason for beta cell collapse. Int Jnl experimental Diab Res 2002; 153–158Google Scholar
- World Health Organization. Obesity: Preventing and managing the Global epidemic. Report of a WHO Consultation on obesity. World Health Organ Tech Rep Ser. 2000; 894:i–xii, 1–253Google Scholar
- Gary T.C. Metabolic Syndrome or Central Obesity SindromeDiabetes Care, 2006; 29(3):752Google Scholar
- Graber A.J., Handelsman Y., Einhorn B., Bergman D.A., Bloomgarden Z.T., Fonseca V., et al Diagnosis and menagment of prediabetes in the continium of hyperglicemia-when do the risk of diabetes begin? A consensus statement from the american college of endocrinology and the american association of clinical endocrinologists. Endocr Pract. 2008; 14(7):933–946Google Scholar
- Perl S., Kushner J.A., Buchholz B.A., Meeker A.K., Stein G.M., Hsieh M. Significant human beta cell turnover is limited to the first three decades of life as determent by in vivo thymidin analog incorporation and radiocarbon dating J.Clin. End. and Metabol 2010; 95(10): 234–239CrossRefGoogle Scholar